PolitiTalkRx

Tom Kraus VP, Government Relations at ASHP  CMS pass through funding What is pass through funding for residency programs and why is it so important? On March 29th the US District Court of South Carolina granted MUSC Health's motion for summary judgment again HHS for their disallowance of PGY1 residency costs. Can you provide some details/background on this case? What was the guidance that CMS was failing to provide? Can speak about ASHP's work with CMS to make the guidance more apparent to other programs moving forward? What will be the downstream effect of this case on residency programs in the future? Can you break down the practice for our listeners? What are the concerns with white bagging? What are the steps being taken at the state and federal level to take action to the concerns related to white bagging? Co-signing letter to the FDA Leveraging PELA and SPPL; can you explain? Partnership with AHA Provider status Can you talk about the work ASHP has done to ensure that pharmacists can provide Medication-assisted treatment (MAT)? At the end of April the US House and Senate introduced the Pharmacy and Medically Underserved Areas Enhancement Act. A similar bill has been submitted for the past couple of years. Can you walk us through the history of this bill? What it would allow pharmacists to do? Why it is so important for the Country? Statistics? This bill continues to have bipartisan support. What do we need to do as pharmacists to finally get this passed? COVID-19 and its effect on provider status and Advocacy Since the start of COVID-19 we've seen congress put forth bills and amendments that outline the healthcare response to the pandemic. One such amendment to the PREP Act outlined that “any physician, advanced practice registered nurse, registered nurse, or practical nurse” who had a license within the last 5 years could participate in the vaccination effort, even if the license was inactive. Pharmacists were left out of this amendment originally. I believe that has since been updated, but what is it that we need to be doing as individuals within the profession to help government officials to understand the worth of pharmacists and consider them as a primary focus in any further legislation? Learn more about your ad choices. Visit megaphone.fm/adchoices

On Dec. 10, 2020, the U.S. Supreme Court ruled 8-0 that an Arkansas law regulating how PBMs and pharmacies interact could be enforced, and was not preempted by federal law. With more than three dozen other states debating or passing such legislation, the ruling could have nationwide impact. The CEOs of national pharmacy organization were unanimous in hailing the decision. In this episode, three guests discuss the case: Rep. Buddy Carter (R-Georgia); John Vinson, CEO of the Arkansas Pharmacists Association; and Scott Knoer, Executive Vice President and CEO of the American Pharmacists Association. See omnystudio.com/listener for privacy information.

Georgia Gov. Brian Kemp (R) has signed three innovative PBM reform bills into law. HB 946 and SB 313 require the reporting of drugs paid 10 percent above and 10 percent below National Average Drug Acquisition Cost every four months, prohibit PBMs from tying a pharmacy's drug reimbursement to a patient's health outcomes, and require PBMs to offer drug coverage plans that do not include spread pricing and plans that allow plan sponsors to receive 100 percent of rebates negotiated by PBMs.  HB 918 strengthens existing anti-steering provisions and the Pharmacy Audit Bill of Rights. Congratulations to the Georgia Pharmacy Association and all pharmacy advocates for these wins which will protect pharmacies, patients, and payers.  Guests: Georgia State Representative David Knight Greg Reybold Vice President of Public Policy and Association Counsel Hosted by Lauren (Colee) Young  Sponsored by The Georgia Pharmacy Association & Pharmacists United for Truth and Transparency (PUTT)    http://www.gpha.org/membership/  See omnystudio.com/listener for privacy information.

PUTTcast Episode 5 - Chatting with VPhA Guests: Christina Barrelle, Executive Director of VPhA, Howard Estes, Attorney & VPhA Lobbyist, Co-Hosts PUTT Executive Director Monique Whitney & PUTT Board President Scott Newman PUTT chats with the Virginia Pharmacists Association about building relationships with state legislators, their recent win in PBM reform, and how they managed to catch the PBM lobby off guard to get things done. See omnystudio.com/listener for privacy information.

As a practicing Pharmacist, Diana Harshbarger could go on for days about the horrible effects Obamacare has had on the healthcare industry, as well as everyday Americans. Health insurance companies and government bureaucrats are out of control. Authority of healthcare choices should be given back to patients and healthcare providers.  While there is much work to be done to eliminate the overreaching arm of the federal government when it comes to healthcare, the first steps Diana will take in Congress will be to lower prescription drug prices, increase generic drug pricing transparency as well as increase competition among health insurance plans. These reforms will make it easier for Americans, especially our seniors, to afford their medications. This episode is sponsored by the University of California Irvine, UCI, Master of Science in Pharmacology, learn more: https://sites.uci.edu/mspharmacology/  See omnystudio.com/listener for privacy information.

PUTTCast Host & Executive Director of PUTT - Monique Whitney talks with:  Kevin Dwayne - Jacksonville FL w/ Panama Rx  Jay Wright - Cocoa FL w/ 5 Points Pharmacy  Amy Rodgers - Little Rock AR  w/ City Pharmacy  A new Florida study, released last week, found that major health care companies using pharmacy benefit managers (PBM's) have positioned themselves to pocket millions of dollars from the state's Medicaid system that were intended to lower costs for millions of low-income Floridians. The study found that despite processing less than half of one percent of all pharmacy claims, specialty pharmacies affiliated with PBM's managed to collect 28 percent of the available profit margin from dispensing prescription drugs. The study was commissioned by the Florida Pharmacy Association and American Pharmacy Cooperative Inc. using data obtained from Florida's Agency for Health Care Administration (AHCA) by the Small Business Pharmacies Aligned for Reform.  Smaller pharmacy operators say the report proves that larger, vertically integrated companies that use PBM's are using “predatory” business practices that short-circuit the free market. State lawmakers expressed alarm at the news and underscored the need for greater transparency and oversight when it comes to PBMs' role in Florida, particularly regarding situations where PBM's and managed care companies own the pharmacies where they direct patients. “Markets fail when markets get corrupted and that is what has happened here. When the middleman is allowed to own the end-retailer then the middlemen's incentive to manage cost appropriately for the benefit of the chain is broken,” said State Representative Randy Fine at a press conference to discuss the study. According to the study, vertically integrated health care companies – that is, companies where the health insurance company and PBM also control their own pharmacies – have a significant advantage in prescription drug pricing and reimbursement rates over smaller pharmacy operations that only focus on dispensing prescription drugs. These large and powerful organizations then use their leverage and contracts with the state to squeeze dollars from their competitors by requiring patients to go to pharmacies where they have a financial interest. This process frequently involves rewarding their own pharmacy operations with significantly higher reimbursement rates from Medicaid, according to the study. The study provided an example of this situation where Sunshine Health directed 95 percent of all claims for generic cancer drug Gleevac to Acaria, its wholly owned specialty pharmacy. It reimbursed this speciality pharmacy an average of $4,399 above the national average cost for the drug. “We have a responsibility to assure that there is no manipulation of prices or anti-competitive practices by PBMs and other entities that result in increased costs to patients and push our local pharmacies out of business,” said State Senator Gayle Harrell. Small pharmacy operations describe PBMs as shadowy prescription drug middlemen whose practices are driving neighborhood pharmacies out of business while reducing access to care for many Floridians. The State of Florida contracts with PBMs to manage Florida's Medicaid program in order to negotiate lower drug prices. But the new study concludes that PBMs have actually cost the public millions of dollars by forcing patients to use PBM-affiliated pharmacies and then charging higher prescription costs. According to Medicaid data contained in the study, one pharmacy in North Miami was responsible for 25% of all managed care claims in Florida for a particular dermatological cream in 2018, receiving a total profit margin of over $1.8 million. The independent study by 3 Axis Advisors reviewed more than 359 million prescription drug claims within Florida's Medicaid program between 2012 and 2019. The information from AHCA was coupled with data from more than 100 pharmacies to determine the impact PBMs have on the portion of the health care system paid by Florida taxpayers through the Medicaid program. See omnystudio.com/listener for privacy information.

NCPA Team Members Anne CassityVP Government Affairs & Karry La Violette Senior Vice President, Government Affairs & Director of Advocacy Center Join us on:  Tuesday and Wednesday, April 21/22, 2020 at the Hilton, Old Town Alexandria.   FLY In. FLY Out. Easy.  That's NCPA's 2020 Congressional Pharmacy Fly-In – a small investment of your time that can make a whopping difference in how federal law and policy affect your pharmacy practice. https://pharmacyflyin.ncpanet.org/ See omnystudio.com/listener for privacy information.

IN DATA WE TRUST Special Guest: ANTONIO CIACCIA with 3 Axis Advisors.  Born and raised in pharmacy, Antonio has been crawling around pharmacies his entire life.  After three years as a pharmacy technician and two years of pre-pharmacy curriculum, Antonio diverted course, graduating from The Ohio State University in 2007 with dual degrees in communications and political science before moving into the world of association management. Thinking that pharmacy would be in his rear-view mirror forever, he ended up making his way back to his pharmacy home, heading up government affairs for the Ohio Pharmacists Association, a trade organization with a strong track record of advocating for drug pricing transparency. After years of studying the pharmacy marketplace, Antonio became increasingly perplexed and concerned as he saw drug costs spiking while payouts to pharmacies were declining. Knowing something was being lost somewhere in the middle of an ever-growing transaction, Antonio has spent years working to crack the drug pricing code and pull the rug out from what he believes is one of the most dysfunctional marketplaces in the world. See omnystudio.com/listener for privacy information.

Pharmacists United for Truth and Transparency (PUTT) is a non-profit advocacy organization founded by independent pharmacists and pharmacy owners devoted to exposing the truth about the anti-competitive tactics of pharmacy benefits managers (PBMs). Known to most Americans as their "prescription drug benefit plan" provider, PBMs are in reality a $300 billion industry - giant corporate middlemen driving up the cost of medications with huge mark ups and commissions on every prescription covered under their "benefits plan."  ​ Working with local and national traditional and digital media that includes The New York Times, USA Today, CBS News, Bloomberg, NBC Nightly News with Lester Holt and Business Insider, PUTT seeks to educate patients, lawmakers, health plan sponsors and the public about the deeply negative effects of the PBM industry on U.S. healthcare and the escalating price of prescription medications. PUTT serves as an industry watchdog, collecting evidence of PBM fraudulent practices and abuse and using this information to educate and inform consumers, taxpayers, employers and health plan sponsors of the truth about the unregulated, unmonitored PBM industry. Through PUTT's efforts, PBMs have begun to experience greater public awareness and scrutiny of their actions and come under fire for questionable practices including the use of gag clauses at the pharmacy counter, gross over-billing of health plans (called "spread pricing"), forcing patients to use PBM-owned pharmacies instead of allowing patients to choose their own pharmacies and interjecting unnecessary bureaucratic practices such as prior authorizations between patients and their doctors in the matter of prescription refills. PUTT members and friends are pharmacists, doctors, patients, consumers, lawmakers, taxpayers and community members. If you've got a story to tell about how PBMs have hurt your pharmacy, your patients, your family or your community, we urge you to join PUTT and help us stop PBM abuse today! See omnystudio.com/listener for privacy information.

Part Two of the PBM Reform Podcast Series features an interview with Monique Whitney, the Excutive Director of Pharmacists United for Truth and Transparency (PUTT).  Pharmacists United for Truth and Transparency (PUTT) is a non-profit advocacy organization founded by independent pharmacists and pharmacy owners devoted to exposing the truth about the anti-competitive tactics of pharmacy benefits managers (PBMs). Known to most Americans as their "prescription drug benefit plan" provider, PBMs are in reality a $300 billion industry - giant corporate middlemen driving up the cost of medications with huge mark ups and commissions on every prescription covered under their "benefits plan."  ​ Working with local and national traditional and digital media that includes The New York Times, USA Today, CBS News, Bloomberg, NBC Nightly News with Lester Holt and Business Insider, PUTT seeks to educate patients, lawmakers, health plan sponsors and the public about the deeply negative effects of the PBM industry on U.S. healthcare and the escalating price of prescription medications. PUTT serves as an industry watchdog, collecting evidence of PBM fraudulent practices and abuse and using this information to educate and inform consumers, taxpayers, employers and health plan sponsors of the truth about the unregulated, unmonitored PBM industry. Through PUTT's efforts, PBMs have begun to experience greater public awareness and scrutiny of their actions and come under fire for questionable practices including the use of gag clauses at the pharmacy counter, gross over-billing of health plans (called "spread pricing"), forcing patients to use PBM-owned pharmacies instead of allowing patients to choose their own pharmacies and interjecting unnecessary bureaucratic practices such as prior authorizations between patients and their doctors in the matter of prescription refills. Monique Whitney Pharmacists United for Truth and Transparency Monique@TruthRx.org m. (505) 480-4150 See omnystudio.com/listener for privacy information.

Anne CassityVice President, Federal and State Government Affairs at National Community Pharmacists Association (NCPA) joins Todd Eury, CEO of the Pharmacy Podcast Network, on part one of the new series:  PBM Reform Podcast Series  Pharmacy benefit managers were created as middlemen to reduce administrative costs for insurers, validate a patient's eligibility, administer plan benefits, and negotiate costs between pharmacies and health plans. Over time, PBMs have been allowed to operate virtually unchecked. A lack of transparency in PBM practices has led several states to implement licensure/registration, fair pharmacy audit, or generic drug pricing legislation to try to level the playing field for pharmacies and patients.  NCPA: https://www.ncpanet.org/advocacy/state-advocacy/pbm-reform  See omnystudio.com/listener for privacy information.

PolitiTalkRx Host Dr Scott Kjelson talks with Colorado State Representative Dylan Roberts about reducing the cost of life saving insulin.  HB19-1216 Reduce Insulin Prices Concerning measures to reduce a patient's costs of prescription insulin drugs, and, in connection therewith, making an appropriation. Prescription insulin drugs - 30-day supply - cost-sharing cap - appropriation.  Effective January 1, 2020, the act caps the cost sharing a covered person is required to pay for prescription insulin drugs at $100 per 30-day supply of insulin. The act requires the department of law to investigate the pricing of prescription insulin drugs and submit a report of its findings to the governor, the commissioner of insurance, and the judiciary committees of the senate and house of representatives. See omnystudio.com/listener for privacy information.

PolitiTalkRx host Scott Kjelson, PharmD talks w/ Brad Tice, PharmD one of the most innovative pharmacists in healthcare helping to position the pharmacist as a healthcare provider while getting paid for patient care services.  About Dr. Tice:  Brad Tice SVP Pharmacy Practice, Aspen RxHealth Founder, RxGenomix President, American Pharmacists Association Brad Tice, PharmD, MBA, FAPhA is the SVP of Pharmacy Practice at Aspen RxHealth and Founder of RxGenomix. He is also the current president of the American Pharmacists Association (APhA).  Dr. Tice received his Bachelor of Science degree in 1994 and PharmD in 1996 from the University of Kansas. He also earned an MBA from the Vanderbilt University Owen School of Management in 2012. His career has spanned the pharmacy spectrum working with independent, chain and hospital pharmacies through Cardinal Health, entrepreneurial start-ups, independent and chain community pharmacy practice, academia at Drake University, and managed care. He is also the founder of RxGenomix, a Tennessee-based company to implement pharmacogenomics into pharmacy practice. See omnystudio.com/listener for privacy information.

PolitiTalkRx host Scott Kjelson, PharmD welcomes special guest ANTONIO CIACCIA  CEO of 46brooklyn Research. 46brooklyn Research is an Ohio non-profit corporation whose purpose is to improve the accessibility and usability of U.S. drug pricing data. 46brooklyn takes the myriad drug pricing data sources scattered across the web and stitches them together into data visualizations that can be used by the public to better understand how the drug supply chain functions. 46brooklyn also writes and publishes original research that uses the data within its public data visualizations to shine light on the hidden and complex underbelly of the drug supply chain. Contact the show:  PolitiTalkRx@gmail.com  See omnystudio.com/listener for privacy information.

Dr. Scott Kjelson, PharmD, host of the PolitiTalkRx Podcast welcomes Edward Li, PharmD, working within Health Economics and Outcomes Research to better understand the value of drugs and biologics. Today Scott & Edward dive into the topic of Biosimilars.  A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product that is almost an identical copy of an original product that is manufactured by a different company. Congress, through the Biologics Price Competition and Innovation Act (BPCI Act) of 2009, created an abbreviated licensure pathway for biological products that are demonstrated to be biosimilar to or interchangeable with an FDA-approved biological product. This pathway was established as a way to provide more treatment options, increase access to lifesaving medications, and potentially lower health care costs through competition. FDA requires biosimilar and interchangeable biological products meet the Agency's rigorous approval standards. That means patients and health care professionals will be able to rely upon the safety and effectiveness of the biosimilar or interchangeable product, just as they would the reference product. See omnystudio.com/listener for privacy information.

PolitiTalkRx Welcomes Pennsylvania Auditor General Eugene DePasquale to the Pharmacy Podcast Network discussing PBM Reform efforts in 2019.  A Pennsylvania report examining the role of pharmacy benefit managers (PBMs) in the state called for more transparency in how they do business managing Medicaid prescriptions. Auditor General Eugene DePasquale said he wanted action to reduce Medicaid prescription costs and called for legislation to: Allow Pennsylvania to directly manage its prescription drug benefits instead of contracting with healthcare managers to do so Increase transparency into PBM pricing practices Allow state oversight of PBM contracts Require a flat-fee pricing model so that the state pays PBMs only for services rendered In 2017, Pennsylvania taxpayers paid $2.86 billion to PBMs for Medicaid enrollees, according to the state Department of Human Services, an increase of 100% in 4 years, up from $1.41 billion in 2013. Pennsylvania Auditor General Calls for Action on PBMs https://www.ajmc.com/newsroom/pennsylvania-auditor-general-calls-for-action-on-pbms  Auditor General DePasquale Demands Increased Oversight of Pharmacy Benefit Managers that Impact Drug Prices https://www.paauditor.gov/press-releases/auditor-general-depasquale-demands-increased-oversight-of-pharmacy-benefit-managers-that-impact-drug-prices  See omnystudio.com/listener for privacy information.

PolitiTalkRx host Scott Kjelson, PharmD, interviews Scott Knoer, PharmD, Chief Pharmacy Officer at Cleveland Clinic about his opinions and views on the coming transformation of the Pharmacy Benefit Managers (PBMs).  NOTE: The views and opinions of this podcast are personal only and not a reflection of any corporation or organization associated with the host or the guests.  Scott Knoer, PharmD  Chief Pharmacy Officer at Cleveland Clinic Contact the show: PolitiTalkRx@Gmail.com  See omnystudio.com/listener for privacy information.

PolitiTalkRx host Dr. Scott Kjelson interviews pharmacy's favorite Congressman Earl L. "Buddy" Carter (R-Ga.) about the opioid epidemic, PBM Reform, drug prices, and Community Pharmacy's leadership towards provider status. About Buddy Carter:  Earl L. “Buddy” Carter is an experienced businessman, health care professional and faithful public servant. As the owner of Carter's Pharmacy, Inc., South Georgians have trusted Buddy with their most valuable assets: their health, lives and families for more than thirty years. While running his business, he learned how to balance a budget and create jobs. He also saw firsthand the devastating impacts of government overregulation which drives his commitment to ensuring that the federal government creates policies to empower business instead of increasing burdens on America's job creators. A committed public servant, Buddy previously served as the Mayor of Pooler, Georgia and in the Georgia General Assembly where he used his business experience to make government more efficient and responsive to the people. Buddy is serving his second term in the United States House of Representatives and is a member of the Committee on Energy and Commerce. As the only pharmacist serving in Congress, Buddy is the co-chair of the Community Pharmacy Caucus and is dedicated to working towards a health care system that provides more choices, less costs and better services. A lifelong resident of the First District, Buddy was born and raised in Port Wentworth, Georgia and is a proud graduate of Young Harris College and the University of Georgia where he earned his Bachelor of Science in Pharmacy. Buddy married his college sweetheart, Amy, 39 years ago. Buddy and Amy now reside in Pooler, Georgia and have three sons, two daughters-in-law and three grandchildren. Contact the host:  PolitiTalkRx@Gmail.com  Four One Two 585-4001 Studios  See omnystudio.com/listener for privacy information.

No one has ever made an impact by standing on the sidelines whimpering, complaining, or protesting without taking action. We make progress by implementing our ideas. Pharmacists must take action.  THIS IS POLITITALKRX, the highly charged, sometimes controversial, political internet radio talk show dedicated to the profession of pharmacy. The policies that shape our healthcare system are complex and pharmacists, pharmacy professionals, and industry stakeholders must have a seat at the table to participate in conversations, discussions, and debates, which lead to actions that drive change supporting the profession of pharmacy. This podcast is intended to shake up the status quo and promote change to improve the profession of pharmacy while advocating for better patient care delivered by pharmacists. PolitiTalkRx is part of the U.S. Healthcare System's largest and most influential network of podcasts dedicated to our profession – the Pharmacy Podcast Network. About the host:  Dr. Scott Kjelson is the Director of Student Transitions and Assistant Professor at Nova Southeastern University's College of Pharmacy. Here Dr. Kjelson focuses on personal and professional development and leadership, major public health forums and community outreach, as well as health care policy within the state of Florida and on a national level. He is currently a member of the Florida Society of Health System Pharmacists Legal and Regulatory Affairs Council, a Board Member of the City of Fort Lauderdale's Community Service Advisory Board, a member of the Broward County's Community Response Team, and an active community leader and mentor. Dr. Kjelson started his career in the U.S. Navy as a Corpsman where he worked as a surgical medic. Following his military experience and undergrad completion at Miami Dade College, he received his Doctorate Degree from Nova Southeastern University College of Pharmacy. Following graduation, he advanced his training and began to work in Long Term Care in Geriatrics as a consultant pharmacist, while also working at the University of Miami Sylvester Comprehensive Cancer Center. His passion for advancing the profession healthcare and being part of the development process lead him to his current role as Director and Assistant Professor at NSU College of Pharmacy. He has been an active community leader while hosting major educational forums and traveling around the nation to help educate other to better understand health care, healthy living, and brand development. Dr. Scott Kjelson has presented around the nation at venues like Johns Hopkins University and General Electric, and his work has been featured on media networks such as Spike TV, Discovery Life, and NPR. His greatest role has been that with his work in combatting the opioid epidemic alongside the local and national law enforcement and policy makers, the United Way, and national health care experts. Dr. Kjelson continues to take on public health issues both in the State of Florida Capital and in Congress in Washington D.C See omnystudio.com/listener for privacy information.

Pharmacy Podcast Network EXCLUSIVE Interview:  Shane Reeves Chief Executive Officer at TwelveStone Health Partners Above all else, Shane Reeves is committed to his five core values of FAITH, FAMILY, CAREER, SERVICE & HEALTH.   After attending Middle Tennessee Christian School and graduating from Oakland High School, Shane continued his education to earn an undergraduate degree from Middle Tennessee State University and a Doctorate of Pharmacy from the University of Tennessee.   After graduation, Shane moved back to Murfreesboro and bought into the family pharmaceutical business with partner Rick Sain. These two men re-named the business Reeves-Sain and proceeded to grow it across the state of Tennessee over two decades providing a number of products and services with specialties in retail pharmacy, compounding, respiratory, infusion therapy, home medical equipment, immunizations, long term care pharmacy and MediPACK. Reeves and Sain sold their retail and specialty pharmacy, Entrust, in the spring of last year. Reeves launched a new pharmaceutical company in February of 2016 called TwelveStone Health Partners.   Shane is proud to be a fourth-generation independent pharmacist, and a seventh-generation resident of Rutherford County. He and his wife, Amanda, have three children, Will, Jack and Emma-White and live in Murfreesboro, where they are active in North Boulevard Church of Christ, where Shane serves as a deacon.     Campaign Website- https://www.reevesfortn.com Campaign Donations- https://secure.anedot.com/reeves/donate Contact Shane- info@reevesfortn.com   See omnystudio.com/listener for privacy information.

About the Pharmacy Podcast Network: In 2009 Todd S. Eury launched the pharmacy industry's first podcast about the Business of Pharmacy dedicated to pharmacist professionals called the ‘Pharmacy Podcast Show'. In 2011, Eury's podcast evolved and in the fall of 2014, several pharmacists joined the podcast publication and the Pharmacy Podcast Show was transformed into the Pharmacy Podcast Network.  As a podcasting 1st in history, the audio-blog publication is the U.S. Healthcare System's largest network of podcasts dedicated to the profession of pharmacy with 23 co-hosts developing content for 15 different podcasts segmented on different topics like healthcare law, technology, medical cannabis, senior care, and pharmacogenomics. The Pharmacy Podcast Network has a collective listener base of about 67,000 and has personalized podcast publications for national associations like the American Society of Consultant Pharmacists and the National Association of Specialty Pharmacy. We embed the podcasts into our sponsors web-environments or they can set up a new page on their site dedicated to the podcasts.  Be sure to see our series sponsor's landing pages:  McKesson Technologies: https://marketing.mckesson.com/2017-MPTS-Pharmacy-Podcast-Series.html Cardinal Health: http://pharmacypodcast.com/podcast_tags/cardinal-health/ H. D. Smith: https://www.hdsmith.com/news-events/podcasts CVS Health: http://pharmacypodcast.com/podcast_tags/cvs-health/ Majority of our podcast episodes are between 17-25 minutes (purposely for the average commute)  With 25 leading co-hosts for 15+ different podcast segments, the PPN develops new content daily for our corporate sponsors including CVS Health, McKesson, Cardinal Health, RxSafe, KeyCentrix, R.J. Hedges & Associates, ASCP, and the NASP.  The folllowing podcasts are part of the PPN: https://soundcloud.com/pharmacy-podcast/sets  Pharmacy Leaders  Pharming Your Career  the Medical PotCast  the Gavel & Pestle Podcast  Specialty Pharmacy Podcast in collaboration w/ the NASP  SenioRx Radio in collaboration w/ the ASCP  the Fit Pharmacist  Pharmacy Inspection Podcast  PolitiTalkRx  PGX for Pharmacists  Pharming Your Career Pharmacy Compliance Guide  the Nontraditional Pharmacist  Income Outcomes Show  Pharmacy Future Leaders  Pharmacy Technician Podcast Please take a look at our co-host intelligence source here, you should be part of this team:  http://pharmacypodcast.com/cohost/ Sincerest thanks to our Listeners & Sponsors,  Thank you.  Todd S. Eury - Founder | Publisher  See omnystudio.com/listener for privacy information.